TD Asset Management’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

TD Asset Management’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-12,386	Closed	-$163K	–	1577
2021 Q2	$163K	Hold	12,386	–	–	﹤0.01%	1491
2021 Q1	$52K	Hold	12,386	–	–	﹤0.01%	1488
2020 Q4	$70K	Buy	+12,386	New	+$50K	﹤0.01%	1432

TD Asset Management's CEREW Position: Q3 2021 in Review

TD Asset Management sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 12,386 shares — an estimated $163K sold.

TD Asset Management first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $163K in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

TD Asset Management reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
TD Asset Management sold 12,386 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $163K.
TD Asset Management first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
TD Asset Management's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $163K in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on TD Asset Management's 13F filing for Q3 2021, filed 9 Nov 2021.